Tesamorelin for Sleep-Disordered Breathing Linked to Late-Night GLP-1 Dosing
Late-night GLP-1 dosing can worsen sleep-disordered breathing. Tesamorelin, a GHRH analog, may reduce visceral fat and improve slow-wave sleep
Read More →INSIGHTS • UPDATES • EDUCATION
Calgary Peptides
BLOG & LEARNING HUB
WELCOME TO THE CALGARY PEPTIDES
BLOG & LEARNING HUB
More than just peptides. Calgary Peptides is a platform for knowledge and progress. Stay informed with expert insights, research updates, protocols, and everything you need to stay ahead in peptide science.
Latest Articles
Can DSIP Counteract Late-Night Peptide Circadian Disruption?
Late-night Tesamorelin injections can delay sleep onset and fragment deep sleep. DSIP, a peptide studied since 1977, may blunt cortisol spikes and ...
Read More →Tesamorelin and DSIP for Night Shift Circadian Disruption
Night shift work disrupts sleep architecture. Tesamorelin and DSIP appear in Russian longevity literature as potential tools, but combination data are
Read More →Can DSIP Mitigate Sleep Disruption From GLP-1 Induced Weight Loss?
GLP-1 agonists can fragment sleep, but delta sleep-inducing peptide (DSIP) may restore normal architecture. Russian research spanning decades
Read More →Tesamorelin and DSIP for Circadian Repair During GLP-1 Sleep Loss
Sleep disruption has emerged as one of the more stubborn companions of GLP-1 receptor agonist therapy. Patients losing weight on semaglutide or
Read More →How the FDA Panel Vote Could Expand Pharmacy Access to DSIP
The FDA panel vote on tesamorelin could indirectly expand pharmacy access to DSIP for shift workers with circadian disruption. Russian research
Read More →